Cancer in the Pancreas. Cancer of the pancreas accounts for only about 2.4% of new cancer diagnoses each year yet it is the fourth most frequent cause of cancer death in both men and women. In 2006, 33,730 people in the United States were diagnosed with pancreatic cancer with an estimated five-year survival rate of 4.6%. (American Cancer Society Facts and Figures 2006).
http://columbiasurgery.org/conditions-and-treatments/pancreatic-cancer
Because more than 95% of pancreatic cancer is the adenocarcinoma type, we'll describe those symptoms first, followed by symptoms of rare forms of pancreatic cancer. The classic Whipple procedure is named after Allen Whipple, MD, a Columbia University surgeon who was the first American to perform the operation in 1935.
http://www.webmd.com/cancer/pancreatic-cancer/whipple-procedure
In the Phase III trial the addition of Virulizin to Gemzar resulted in a median overall survival of 6.8 months and a one-year survival rate of 27.2% compared with six months and 16.8% for Gemzar alone. 16 Virulizin is not currently FDA approved for the treatment of pancreatic cancer in the United States.
http://www.texasoncology.com/types-of-cancer/pancreatic-cancer/stage-ii-pancreatic-cancer/
Herceptin® (trastuzumab): Herceptin is a monoclonal antibody, which is a type of targeted therapy that binds to the HER2 receptor, (a protein on the surface of the cancer cells) in approximately 20% of patients with pancreatic cancer.
http://www.texasoncology.com/types-of-cancer/pancreatic-cancer/stage-ii-pancreatic-cancer/
The following is a general overview of treatment for Stage II pancreatic cancer. Treatment may consist of surgery, radiation, chemotherapy, biological therapy, or a combination of these treatment techniques.
http://www.texasoncology.com/types-of-cancer/pancreatic-cancer/stage-ii-pancreatic-cancer/
Many patients with Stage II pancreatic cancer already have small amounts of cancer that have spread outside the pancreas (micrometastases). An effective systemic treatment is needed to cleanse the body of micrometastases in order to improve a patient’s duration of survival and potential for cure.
http://www.texasoncology.com/types-of-cancer/pancreatic-cancer/stage-ii-pancreatic-cancer/
Also known as pancreaticoduodenectomy, the Whipple procedure involves removal of the head (wide part) of the pancreas next to the first part of the small intestine (duodenum). It also involves removal of the duodenum, a portion of the common bile duct, gallbladder, and sometimes part of the stomach.
http://www.webmd.com/cancer/pancreatic-cancer/whipple-procedure
Future progress in the treatment of Stage II pancreatic cancer will result from the continued evaluation of new treatments in clinical trials. Participation in a clinical trial may offer patients access to better treatments and advance the existing knowledge about treatment of this cancer.
http://www.texasoncology.com/types-of-cancer/pancreatic-cancer/stage-ii-pancreatic-cancer/
Among common cancers, pancreatic cancer has one of the poorest prognoses. Because pancreatic cancer often grows and spreads long before it causes any symptoms, only about 6% of patients are still alive five years after diagnosis. For some pancreatic patients, however, a complex surgery known as the Whipple procedure may extend life and could be a potential cure. Those who undergo a successful Whipple procedure may have a five-year survival rate of up to 25%.
http://www.webmd.com/cancer/pancreatic-cancer/whipple-procedure
Pancreas and Cancer-Survival Rate. Depending upon many factors, treatment of pancreatic cancer may include surgery, chemotherapy and/or radiation. Other sections of this website explain when and why the various treatment modalities are employed.
http://columbiasurgery.org/conditions-and-treatments/pancreatic-cancer
what is the cure rate for pancreatic cancer
The cure rate for pancreatic cancer is 4.6 percent.  The cure rate for pancreatic cancer is 4.6%.